Josef Pichler

3.2k total citations
55 papers, 1.2k citations indexed

About

Josef Pichler is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Josef Pichler has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Genetics, 18 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Josef Pichler's work include Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Josef Pichler is often cited by papers focused on Glioma Diagnosis and Treatment (39 papers), Brain Metastases and Treatment (11 papers) and Cancer, Hypoxia, and Metabolism (6 papers). Josef Pichler collaborates with scholars based in Austria, Germany and Switzerland. Josef Pichler's co-authors include Serge Weis, Sabine Spiegl‐Kreinecker, Walter Berger, Daniela Lötsch, Christine Pirker, Matthias Preusser, Gerald Webersinke, Anna S. Berghoff, Peter Birner and Monika Hackl and has published in prestigious journals such as Journal of Clinical Oncology, Oncogene and Clinical Cancer Research.

In The Last Decade

Josef Pichler

47 papers receiving 1.2k citations

Peers

Josef Pichler
Constantina Petraki Greece
Kaishi Satomi Japan
Kirsten van Lom Netherlands
Debra Saxe United States
K Michalová Czechia
András Matolcsy Hungary
Jesper Jurlander Denmark
Hormoz Ehya United States
Mariantonia Carosi Italy
Thierry Lavabre‐Bertrand France
Constantina Petraki Greece
Josef Pichler
Citations per year, relative to Josef Pichler Josef Pichler (= 1×) peers Constantina Petraki

Countries citing papers authored by Josef Pichler

Since Specialization
Citations

This map shows the geographic impact of Josef Pichler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Josef Pichler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Josef Pichler more than expected).

Fields of papers citing papers by Josef Pichler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Josef Pichler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Josef Pichler. The network helps show where Josef Pichler may publish in the future.

Co-authorship network of co-authors of Josef Pichler

This figure shows the co-authorship network connecting the top 25 collaborators of Josef Pichler. A scholar is included among the top collaborators of Josef Pichler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Josef Pichler. Josef Pichler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pichler, Josef, Tatjana Traub‐Weidinger, Arthur J. A. T. Braat, et al.. (2024). Results from a phase I study of 4- l -[131I]iodo-phenylalanine ([131I]IPA) with external radiation therapy in patients with recurrent glioblastoma (IPAX-1). Neuro-Oncology Advances. 6(1). vdae130–vdae130. 4 indexed citations
2.
3.
Mair, Maximilian J., Martin Aichholzer, Georg Widhalm, et al.. (2023). 528P Progression risk after pregnancy in patients with glioma. Annals of Oncology. 34. S402–S402.
4.
Pichler, Josef. (2023). ASCO 2023: new treatment options in CNS tumors. memo - Magazine of European Medical Oncology. 16(4). 222–224.
5.
Mair, Maximilian J., Gerwin Heller, Rainer Puhr, et al.. (2022). Early Postoperative Treatment versus Initial Observation in CNS WHO Grade 2 and 3 Oligodendroglioma: Clinical Outcomes and DNA Methylation Patterns. Clinical Cancer Research. 28(20). 4565–4573. 8 indexed citations
6.
Galijašević, Malik, Stephanie Mangesius, Hans H. Goebel, et al.. (2022). MRI Response Assessment in Glioblastoma Patients Treated with Dendritic-Cell-Based Immunotherapy. Cancers. 14(6). 1579–1579. 7 indexed citations
7.
Pichler, Josef, Serge Weis, Philipp Hermann, et al.. (2022). Frequency and characteristics of bacterial and viral low-grade infections of the intervertebral discs: a prospective, observational study. Journal of Orthopaedics and Traumatology. 23(1). 15–15. 9 indexed citations
8.
Leitner, J., Maximilian J. Mair, Stephan Meckel, et al.. (2021). Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature. Journal of Neurology. 269(3). 1574–1590. 13 indexed citations
9.
Lampl, Christian, et al.. (2018). Re-irradiation of recurrent glioblastoma as part of a sequential multimodality treatment concept. Clinical & Translational Oncology. 21(5). 582–587. 12 indexed citations
10.
Wick, Wolfgang, Harald Fricke, Klaus Junge, et al.. (2014). A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma. Clinical Cancer Research. 20(24). 6304–6313. 95 indexed citations
11.
Platten, Michael, Harald Fricke, Klaus Junge, et al.. (2014). Final results of APG101_CD_002: APG101 plus reirradiation versus reirradiation in the treatment of patients with progressive glioblastoma.. Journal of Clinical Oncology. 32(15_suppl). 2006–2006. 2 indexed citations
12.
13.
Höfer, Silvia, Katarzyna Elandt, Richard Greil, et al.. (2011). Clinical outcome with bevacizumab in patients with recurrent high-grade glioma treated outside clinical trials. Acta Oncologica. 50(5). 630–635. 36 indexed citations
14.
Pichler, Josef & Christine Marosi. (2010). Medikamentöse Therapien bei Patienten mit rezidivierten Glioblastomen: Versuch einer Standortbestimmung. Wiener Medizinische Wochenschrift. 161(1-2). 26–31. 2 indexed citations
15.
Mühlbauer, Bernd, et al.. (2009). Off-Label Use of Prescription Drugs in Childhood and Adolescence. Deutsches Ärzteblatt international. 106(3). 25–31. 29 indexed citations
16.
Fischer, Hendrik, Sabine Spiegl‐Kreinecker, Christine Gauglhofer, et al.. (2008). FGF5 as an oncogenic factor in human glioblastoma multiforme: autocrine and paracrine activities. Oncogene. 27(30). 4180–4190. 84 indexed citations
17.
Spiegl‐Kreinecker, Sabine, Christine Pirker, Christine Marosi, et al.. (2007). Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma. British Journal of Cancer. 96(6). 960–969. 29 indexed citations
18.
Haŭtmann, Hŭbert, Josef Pichler, Herbert Stepp, et al.. (2007). In-vivo kinetics of inhaled 5-Aminolevulinic acid-Induced Protoporphyrin IX fluorescence in bronchial tissue. Respiratory Research. 8(1). 33–33. 15 indexed citations
19.
Häußinger, K, Franz Stanzel, R. Huber, Josef Pichler, & Herbert Stepp. (1999). Autofluorescence Detection of Bronchial Tumors With the D‐Light/AF. Diagnostic and therapeutic endoscopy. 5(2). 105–112. 36 indexed citations
20.
Beer, Martin, et al.. (1997). Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhea virus. Veterinary Microbiology. 58(1). 9–22. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Constantina Petraki Breakdown of academic impact, for papers by Kaishi Satomi Breakdown of academic impact, for papers by Kirsten van Lom Breakdown of academic impact, for papers by Debra Saxe Breakdown of academic impact, for papers by K Michalová Breakdown of academic impact, for papers by András Matolcsy Breakdown of academic impact, for papers by Jesper Jurlander Breakdown of academic impact, for papers by Hormoz Ehya Breakdown of academic impact, for papers by Mariantonia Carosi Breakdown of academic impact, for papers by Thierry Lavabre‐Bertrand
Rankless by CCL
2026